Fibrin Sealant for Prevention of Resection Surface-Related Complications After Liver Resection: A Randomized Controlled Trial

Objective:To evaluate the efficacy of fibrin sealant in reducing resection surface-related complications in liver surgery. Background:Bile leakage, bleeding, and abscess formation are major resection surface-related complications after liver resection. It is unclear whether application of fibrin sealant to the resection surface is effective in reducing these complications. Methods:In a multicenter, randomized trial in 310 noncirrhotic patients undergoing liver resection, we compared prophylactic application of fibrin sealant to the resection surface (156 patients) with no application of fibrin sealant (154 patients). In addition to clinical assessments, patients underwent protocolized computerized tomography (CT) scan 1 week postoperatively. Primary endpoint was a composite of postoperative resection surface-related complications (bile leakage, bleeding, or abscess), as adjudicated by a clinical-events committee that was unaware of the study-group assignments. Results:Overall rate of resection surface-related complications was not different between the 2 groups: 24% (38/156 patients) in the fibrin sealant group and 24% (37/154 patients) in the control group. Bile leakage was detected in 14% of patients in the fibrin sealant group and in 14% of controls. CT scans showed a fluid collection at the resection surface 100 mL or more in 28% of patients in the fibrin sealant group and in 26% of controls (P = 0.800). The rate of reinterventions for resection surface-related complications (12% vs 10%; P = 0.492) and severity of complications did also not differ between the 2 groups. Conclusions:This randomized multicenter trial shows that prophylactic application of fibrin sealant at the resection surface after liver resections does not lead to a reduction in the incidence or severity of postoperative bile leakage or other resection surface-related complications (Controlled trial number, ISRCTN85205641).

[1]  K. Bandeen-Roche,et al.  Appendix 1 , 2019, European Journal of Human Genetics.

[2]  R. Porte,et al.  Fibrinolytic Proteins in Human Bile Accelerate Lysis of Plasma Clots and Induce Breakdown of Fibrin Sealants , 2012, Annals of Surgery.

[3]  R. Ciria,et al.  A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection. , 2010, Archives of surgery.

[4]  S. Wigmore,et al.  Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  C. Dejong,et al.  Feasibility of randomized controlled trials in liver surgery using surgery‐related mortality or morbidity as endpoint , 2009, The British journal of surgery.

[6]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .

[7]  R. Porte,et al.  Topical haemostatic agents in liver surgery: do we need them? , 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  T. Serrano,et al.  Application of Fibrin Glue Sealant After Hepatectomy Does Not Seem Justified: Results of a Randomized Study in 300 Patients , 2007, Annals of surgery.

[9]  A. Muratore,et al.  Bile leakage and liver resection: Where is the risk? , 2006, Archives of surgery.

[10]  S. Makimoto,et al.  New method for prevention of bile leakage after hepatic resection , 2006, Journal of surgical oncology.

[11]  H. Lippert,et al.  Sealing of the hepatic resection area using fibrin glue reduces significant amount of postoperative drain fluid. , 2005, World journal of gastroenterology.

[12]  H. Mischinger,et al.  Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial , 2005, Langenbeck's Archives of Surgery.

[13]  N. Heaton,et al.  Comparison of a new fibrin sealant with standard topical hemostatic agents. , 2004, Archives of surgery.

[14]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[15]  M. Gonen,et al.  Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  D. Albala.  Fibrin sealants in clinical practice. , 2003, Cardiovascular surgery.

[17]  K. McMasters,et al.  Decreasing mortality of bile leaks after elective hepatic surgery. , 2003, American journal of surgery.

[18]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[19]  M. Fukayama,et al.  Parathyroid Adenoma Manifested by Mediastinal Hemorrhage: Report of a Case , 2002, Surgery Today.

[20]  M. Makuuchi,et al.  Randomized trial of the usefulness of a bile leakage test during hepatic resection. , 2000, Archives of surgery.

[21]  W. Chapman,et al.  Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. , 2000, Archives of surgery.

[22]  S. Fan,et al.  Biliary complications after hepatic resection: risk factors, management, and outcome. , 1998, Archives of surgery.

[23]  D. Nagorney,et al.  Trends in Morbidity and Mortality of Hepatic Resection for Malignancy A Matched Comparative Analysis , 1994, Annals of surgery.

[24]  N. Nagasue,et al.  Comparison of topical hemostatic agents in elective hepatic resection: A clinical prospective randomized trial , 1992, World Journal of Surgery.

[25]  D. Bentrem,et al.  Surgical therapy for metastatic disease to the liver. , 2005, Annual review of medicine.

[26]  J. Fleshman,et al.  Liver resection for colorectal metastases. , 2004, Annals of the Royal College of Surgeons of England.

[27]  Ph.D. Hiroshi Shimada M.D.,et al.  Risk Factors and Management of Bile Leakage after Hepatic Resection , 2003, World Journal of Surgery.

[28]  S. Todo,et al.  Control of Intraoperative Bleeding During Liver Resection: Analysis of a Questionnaire Sent to 231 Japanese Hospitals , 2002, Surgery Today.

[29]  P. Balladur,et al.  Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. , 1996, Hepato-gastroenterology.